The researchers first used quantitative immunofluorescence to show that high prostate cancer expression of eIF4A (compared to its levels in adjacent benign tissue) was strongly associated with high-risk features in 370 human prostate cancer…
The researchers first used quantitative immunofluorescence to show that high prostate cancer expression of eIF4A (compared to its levels in adjacent benign tissue) was strongly associated with high-risk features in 370 human prostate cancer…